Approval · Notice of Compliance 294 · 2004
RYTHMOL SR: Notice of Compliance 294
Issued March 29, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 294
- Date
- March 29, 2004
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New formulation and indication: sustained-release capsules to prolong the time to recurrence of symptomatic atrial arrhythmias in patients without significant structural heart disease and with a history of symptomatic atrial fibrillation
- Therapeutic class
- Antiarrhythmic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RYTHMOL SR | 02251485 | — |
| RYTHMOL SR | 02251493 | — |
| RYTHMOL SR | 02251507 | — |
Medicinal ingredients
- PROPAFENONE HCL 225 MG per CAP
- PROPAFENONE HCL 325 MG per CAP
- PROPAFENONE HCL 425 MG per CAP